- Home
- GTEC vs LSTA Comparison
GTEC vs LSTA Comparison
Compare GTEC & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GTEC
- LSTA
- Stock Information
- Founded
- GTEC 2006
- LSTA 1980
- Country
- GTEC United States
- LSTA United States
- Employees
- GTEC N/A
- LSTA N/A
- Industry
- GTEC Industrial Machinery/Components
- LSTA Misc Health and Biotechnology Services
- Sector
- GTEC Industrials
- LSTA Health Care
- Exchange
- GTEC Nasdaq
- LSTA Nasdaq
- Market Cap
- GTEC 35.8M
- LSTA 22.5M
- IPO Year
- GTEC N/A
- LSTA N/A
- Fundamental
- Price
- GTEC $1.87
- LSTA $2.61
- Analyst Decision
- GTEC
- LSTA Strong Buy
- Analyst Count
- GTEC 0
- LSTA 1
- Target Price
- GTEC N/A
- LSTA $15.00
- AVG Volume (30 Days)
- GTEC 128.7K
- LSTA 23.5K
- Earning Date
- GTEC 08-14-2025
- LSTA 08-11-2025
- Dividend Yield
- GTEC N/A
- LSTA N/A
- EPS Growth
- GTEC N/A
- LSTA N/A
- EPS
- GTEC 1.14
- LSTA N/A
- Revenue
- GTEC $82,898,634.00
- LSTA $1,000,000.00
- Revenue This Year
- GTEC $3.28
- LSTA N/A
- Revenue Next Year
- GTEC N/A
- LSTA N/A
- P/E Ratio
- GTEC $1.68
- LSTA N/A
- Revenue Growth
- GTEC N/A
- LSTA N/A
- 52 Week Low
- GTEC $1.17
- LSTA $1.87
- 52 Week High
- GTEC $2.94
- LSTA $4.20
- Technical
- Relative Strength Index (RSI)
- GTEC 46.91
- LSTA 52.43
- Support Level
- GTEC $1.95
- LSTA $2.34
- Resistance Level
- GTEC $2.09
- LSTA $3.09
- Average True Range (ATR)
- GTEC 0.11
- LSTA 0.25
- MACD
- GTEC -0.01
- LSTA 0.01
- Stochastic Oscillator
- GTEC 28.72
- LSTA 50.67
About GTEC Greenland Technologies Holding Corporation
Greenland Technologies Holding Corp is a developer of quality solutions in the material handling industry. It is a transmission and drivetrain systems provider for material handling equipment such as forklift trucks for industrial and logistic applications. Geographically, the company has its presence in Domestic and International markets and earns majority of the revenue from Domestic Sales.
About LSTA Lisata Therapeutics Inc.
Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.